Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.
Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong preliminary first-quarter net sales guidance.
STAAR Surgical shares jumped 13.3% to $44.30 on Thursday.
NOVONIX Limited (NASDAQ:NVX, ASX: NVX)))) ("NOVONIX" or the "Company"), a leading battery materials and technology company, today announced that upon recommendation by the U.S. Department of Energy ("DOE"), the Company